Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
ABSTRACT Nutritional iron deficiency anemia is the most common deficiency disorder, affecting more than two billion people worldwide. Oral iron supplementation is usually the first choice for the treatment of iron deficiency anemia, but in many conditions, oral iron is less than ideal mainly because of...
Main Authors: | João Ricardo Friedrisch, Rodolfo Delfini Cançado |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Revista Brasileira de Hematologia e Hemoterapia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842015000600400&lng=en&tlng=en |
Similar Items
-
Comparison of the use of intravenous iron sucrose with intravenous ferric Carboxymaltose for treatment of iron deficiency anaemia in pregnant patients
by: Khar un-Nisa, et al.
Published: (2022-11-01) -
Evaluation of Minimal Optimal Dose of Intravenous Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia and Risk of Transient Hyperferritinemia
by: Alharbi AA, et al.
Published: (2022-11-01) -
A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia – reply
by: Rodolfo Delfini Cancado, et al.
Published: (2020-01-01) -
Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01)